SOVREMENNAYA PEDIATRIYA.2016.2(74):84-88; doi 10.15574/SP.2016.74.84 

Combined preparations in the treatment of acute rhinitis in children 

Marushko Y., Moskovenko E. D.

A.A. Bogomolets National Medical University, Kiev, Ukraine 

Objective — to generalize the experience of the use of a combined preparation «Milt nasal drops» in the treatment of acute rhinitis in children with acute respiratory infections. 

Patients and methods. A total of 42 children (20 boys and 22 girls) with mild and moderate ARVI in age from 6 months to 5 years were under observation. In 18 (42.9%) children were found different manifestations of allergy. All the children had clinical symptoms of acute rhinitis such as nasal congestion, runny nose, itching, sneezing, watery eyes and twang. In the complex treatment patients had received «Milt nasal drops» preparation in age dosage. 

Results. Already on the second day of the treatment, all patients had positive dynamics of the rhinitis symptoms. In 32 children «Milt nasal drops» was canceled due to the clinical indications (absence of manifestations of rhinitis) on the 5th day of treatment. Side effects during the treatment by preparation were not found. Conclusions. Use of a combined preparation «Milt nasal drops» contributes to the elimination of the clinical manifestations of acute rhinitis in children with ARVI, effectively and safely, including children with atopic reactions. 

Key words: acute respiratory viral infection, acute rhinitis, children, treatment. 

REFERENCES

1. Allergologiya i immunologiya. Pod red AA Baranova i RM Haitova. 2-e izd, isp i dop. Moskva, Soyuz pediatrov Rossii. 2010: 248.

2. Besh LV. 2012. Alerhichnyi rynit u ditei. Zdorove rebenka. 5(40): 35—37.

3. Guschin IS. 2009. Perspektivyi sovershenstvovaniya protivoallergicheskogo deystviya N1-antigistaminnyih preparatov. Lechaschiy vrach. 5: 14—17.

4. Zaytseva OV. 2011. Podhodyi k diagnostike i lecheniyu allergicheskogo rinita. Vestnik otorinolaringol. 5: 62—65.

5. Volosovets AP i dr. 2007. Ispolzovanie nazalnyih dekongestantov v pediatricheskoy praktike. Zdorov'ya Ukrayini. 5(1): 56.

6. Krivopustov SP. 2009. Ostryie rinityi u detey. Dityachiy likar. 1: 15—18.

7. Ovcharenko LS, Vertegel AA, Andrienko TG i dr. 2008. Nazalnyie dekongestantyi i solevyie rastvoryi dlya lecheniya rinitov u detey: bezopasnost i perspektivyi. Zdorove Ukrainyi. 18(1): 42—43.

8. Revyakina VA. 2010. Allergicheskiy rinit u detey. Sovremennyie tendentsii v diagnostike i terapii. Consilium medicum. Pediatriya. 2: 29—34.

9. Groger M, Klemens C, Wendt S et al. 2012. Mediators and cytokines in persistent allergic rhinitis and nonallergic rhinitis with eosinophilia syndrome. Int Arch Allergy Immunol. 159(2): 171—178. http://dx.doi.org/10.1159/000336169; PMid:22652688

10. Westman M, Stjarne P, Asarnoj A et al. 2012. Natural course and comorbidities of allergic and nonallergic rhinitis in children. J Allergy Clin Immunol. 129(2): 403—408. http://dx.doi.org/10.1016/j.jaci.2011.09.036; PMid:22056609

11. Ameille J, Hamelin K, Andujar P et al. 2013, Feb. 6. Occupational asthma and occupational rhinitis: the united airways disease model revisited. Occup Environ Med. http://dx.doi.org/10.1136/oemed-2012-101048; PMid:23390199 PMCid:PMC3908889

12. Compalati E, Penagos M, Tarantini F et al. 2009. Specific immunotherapy for respiratory allergy: state of the art according to current meta-analyses. Ann Allergy AsthmaImmunol. 102; 1: 22—28. http://dx.doi.org/10.1016/S1081-1206(10)60103-2